Cash Flow Statement

Cellectis (CLLS) Other Operating Expenses (2023)

Cellectis has reported Other Operating Expenses over the past 1 years, most recently at -$64.0 million for Q4 2023.

  • Quarterly results put Other Operating Expenses at -$64.0 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$41.7 million (down 160.29% YoY), and the annual figure for FY2025 was $638000.0, down 24.85%.
  • Other Operating Expenses for Q4 2023 was -$64.0 million at Cellectis, down from $22.3 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for CLLS hit a ceiling of $25.7 million in Q2 2023 and a floor of -$64.0 million in Q4 2023.